维普期刊资源整合服务平台（V6.5）

45篇 您的检索式：作者名="Vrhovec"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Improved predic- tion of decreased creatinine clearance by serum cys- tatin C :use in caner patients before and during chem- otherapy 显示文摘	Stabuc B Vrhovec L Silih M	2000	Clin Chem2000，4，2：	1
2	Prognostic and predictive value of the urokinase-type plasminogen activator and its inhibitors PAI-1 and PAI-2 in operable breast cancer显示文摘	Cufer T Borstnar S Vrhovec I	2003	Int-J-Biol-Markers2003，18，2：	1
3	Improved prediction of decreased creatinine clearance by serum cystatin C: use in cancer patients before and during chemotherapy 显示文摘	Stabuc B Vrhovec L Stabuc-Silih M	2000	Clin Chem2000，46，2：	1
4	Improved prediction of decreased creatinine clearance by serum cystatin C:use in cancer patients before and during chemotherapy显示文摘	Stabuc B Vrhovec L Stabuc-Silih M		Clinical Chemistry0，，：	1
5	Improved prediction of decreased creatinine clearance by serum cystatin C:use in cancer patients before and during chemotherapy显示文摘	Stabuc B Vrhovec L Stabuc-Silih M	2000	Clin Chem2000，46，：	1
6	Improved predic- tion of decreased creatinine clearance by serum cystatin C: use in cancer patients before and during chemotherapy 显示文摘	Stabuc B Vrhovec L Stabuc-Silih M	2000	Clin Chem2000，46，2：	1
7	Imporved prediction of decreased creatinine clearance by serum cystatin C : use in cancer patients before and during chemotherapy显示文摘	Stabuc B Vrhovec L Stabuc-Silih M	2000	Clin Chem2000，46，2：	1
8	Prognostic value of the urokinase-type plasminogen activator,and its inhibitors and receptor in breast cancer patients显示文摘	Borstnar S Vrhovec I Svetic B	2002	Clin Breast Cancer2002，3，2：	1
9	Prognostic and predictive value of cathepsins D and L in operable breast cancer patients 显示文摘	Vrhovec I Borstnar S	2005	Neoplasma2005，52，1：	1
10	Improved prediction of decreased creatinine clearance by serum cystatin C: Use in cancer patients before and dring chemotherapy显示文摘	Stbuc B Vrhovec L Stabuc-Silih M		0，，：	1
11	Improved prediction of decreased creatinine clearance by serum cystatin C: use in cancer patients before and during chemotherapy显示文摘	Stabuc B Vrhovec L Stabuc-Silih M	2000	Clin Chem2000，46，2：	1
12	Plamaa cystatin C is superior to 24 h creafinine clearance and plasrm creatinine for estimation of glomerular filtration rate 3 months after kidney wartsplantatior 显示文摘	Stabuc B Vrhovec L Stabuc Silih M	2000	Cin Chem2000，46，8：	1
13	Prognostic and predictive value of the urokinse-type plasminogen activator (uPA) and its inhibitors PAI-1 and PAI-2 in operable breast cancer显示文摘	Curer T Borstnar S Vrhovec J	2003	Int J Biol Markers2003，18，2：	1
14	Improved prediction of decreased creatinine clearance by serum cystatin C:Use in cancer patients before and during chemotherapy显示文摘	Stabuc B Vrhovec L Stabuc-Silih M	2000	Clin Chem2000，46，2：	1
15	Improved prediction of decreased creatinine clearance by serum cystatin C : use in cancer patients before and during chemotherapy显示文摘	STABUC B VRHOVEC L STABUC SILIH M	2000	Clin Chem2000，46，2：	1
16	Prognostic and predictive value of the urokinase - type plasminogen activator (uPA) and its inhibitors PAI- 1 and PAI-2 in operable breast cancer显示文摘	Cufer T Borstnar S Vrhovec I	2003	Int J Biol Markers2003，18，2：	1
17	Improved prediction of decreased creatinine clearance by serum Cystatin C:use in cancer patients before and during chemotherapy显示文摘	Stabuc B Vrhovec L Stabuc-Silih M	2000	Clin Chem2000，46，2：	1
18	Prognostic and predictive value of cathepsins D and L in operable breast cancer patients显示文摘	Jagodic M Vrhovec I Borstnar S	2005	Neoplasma2005，52，1：	1
19	Improved prediction of decreased creatinine clearance by serum cystatin C: use in cancer patients before and during chemotherapy显示文摘	Vrhovec L Stabuc - Silih M	2000	Clin Chem2000，46，：	1
20	Prognostic and predictive value of cathepsins D and L in operable breast cancer patients显示文摘	JAGODIC M VRHOVEC I BORSTNAR S	2005	Neoplasma2005，52，1：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示